Skip to content

13F-HR filed by Indaba Capital Management, L.P.

Indaba Capital Management, L.P. filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 9 holding rows worth $233,708,134.

Accession
0001011438-24-000663
Filed
2024-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2024

A holdings report, 9 entries on the cover page, a total value of $233,708,134 stated on the cover page (in dollars after the unit check, H1), rows summing to $233,708,134 with VALUE read as dollars as filed, 13F file number 028-16058. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
EQUITY COMMONWEALTH294628102COM SH BEN INT4,700,000$93,530,000dollars as filed
Esperion Therapeutics Inc29664WAB1NOTE 4.000%11/15/2533,750,000$32,018,625dollars as filedprincipal
BANDWIDTH INC05988JAD5NOTE 0.500% 4/040,250,000$31,407,075dollars as filedprincipal
ON24 INC68339B104COM4,240,256$25,950,367dollars as filed
XOMETRY INC98423FAB5NOTE 1.000% 2/021,750,000$18,550,575dollars as filedprincipal
ACCELERATE DIAGNOSTICS INC00430HAC6NOTE 5.000%12/124,083,901$12,410,434dollars as filedprincipal
IRONWOOD PHARMACEUTICALS INC46333XAH1NOTE 1.500% 6/19,000,000$7,961,400dollars as filedprincipal
STANDARD BIOTOOLS INC34385PAF5NOTE 5.250%12/07,660,000$7,631,658dollars as filedprincipal
SUMMIT HOTEL PPTYS866082AA8NOTE 1.500% 2/14,500,000$4,248,000dollars as filedprincipal

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001011438-24-000663this filing2024-11-14acceptance time not in the bulk data set